PI Industries Limited CC-May26.pdf · 2026-05-20
Thank you for the opportunity. So, my question has to do a bit with the client that we are serving for our biggest molecule. So, since they have come up with a guidance of their formulation in which they use our molecule, they have come up with a guidance of beating their conservative guidance of full year of last year. And so I am just trying to understand if our shipments to this client of ours is going to get better in the upcoming quarters. So, what I am trying to understand is if we will have growth on our Agchem export side which is dominated by one single molecule. Do we see traction in that molecule going forward? Will we see volumes picking up in that molecule specifically for the next couple of quarters?
Right. Just to follow up on that since I know we have addressed about the contract assets already on the call, but we have seen a reduction of contr act assets going from Q3 FY26 to Q4 FY26. So, does this mean that we are basically billing our clients an d they are actually drawing up on the reserves of our contract assets? So, would we see this trend moving forward let us say by Q1 ‘27, Q2 and Q3 ‘27?